Kidney Disease
167
24
26
108
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
29 trials with published results (17%)
Research Maturity
108 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.0%
10 terminated out of 167 trials
91.5%
+5.0% vs benchmark
25%
41 trials in Phase 3/4
27%
29 of 108 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 108 completed trials
Clinical Trials (167)
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
Immune System Related Kidney Disease
Effects of an Exercise and Diet Program on Biochemistry and Body Composition in Patients With CKD in G1 and G2 Stages
An Intensive Lifestyle Intervention Program in CKD (Move to Health 2)
Rutgers University Study of the Genetics of Kidney Disease
Transgender Analysis of Nephrological Studies Focused on Renal Metrics
Developing a Learning Health System for Primary Care in Thailand
Renal and Hepatic Abnormal Doppler Patterns in Trauma
Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
Search for New Methods to Detect Acute Renal Failure
Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3
Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria
Older Kidney Patient Optimisation Pretransplant
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration of New Diagnostic Devices
A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy
Randomized Trial of SGLT2i in Heart Transplant Recipients